Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Immunohistochemical analysis of patients with oral BSCC, W/MSCC and PDSCC

From: Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?

Antibodies No. of cases (%)  
  BSCC PDSCC W/MSCC p value*
E-cadherin        
 Weak immunostaining 15 88.2 21 80.8 15 53.6 .019
 Strong immunostaining 2 11.8 5 19.2 13 46.4
 β-catenin        
 Weak immunostaining 10 58.8 20 76.9 20 71.4 .355
 Strong immunostaining 7 41.2 6 23.1 8 28.6
Total 17 100 26 100 28 100  
  1. Abbreviations: BSCC basaloid squamous cell carcinoma, PDSCC poorly differentiated squamous cell carcinoma, W/MSCC well to moderately differentiated squamous cell carcinoma.
  2. *Analysis by chi-square test at 5% significance level.
Back to article page